Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway

Yulin Peng(Dalian Medical University), Chuanzhu Lv(Hainan Medical University)
Journal of Experimental & Clinical Cancer Research
October 12, 2018
Cited by 174


Related Papers